Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on Oct 27, 2024 8:56am
310 Views
Post# 36283867

Big Pharma couldn't do it...

Big Pharma couldn't do it...The last two weeks were very interesting.
1) The SP did increase by 100%, nobody know exactly why, but because of that 100%, TLT did get some visibility, as a result new investors started a position in TLT.

2) The SP did retract, nobody on this board did expect a 100% increase without some investors taking a profit.

3) Today the SP is still 53% higher than it was before it all started (not bad).

4) Ours most annoying poster (posting +15 useless posts each day), has finally openly admitted that he was a full-fledged basher and a penny flipper(although the longs on this board already knew he was).

Question?
Will the SP continue to decrease?
Answer.
It doesn't matter, the FDA doesn't care about the SP, the FDA care only about the data, and TLT data are rock solid.


Merck's(+200 billion market cap).
Merck's has Keytruda, with a very low 19CR%, and a ton of side effects.

Johnson &Johnson(+400 billion market cap).
J&J has Tar-200 with an anemic 4.7CR% on the long term.

Note: 
TLT management with a shoestring budget did better than the biggest Pharma Company in the world.
The above could explain why bashers keep trying to discredit TLT management.

Keep in mind...as we speak, with the best data in the business, TLT has a big foot inside the FDA, and TLT is working hand in hand with the FDA to approve this much needed '' one and done '' treatment for BCG resistant patients.

For now, forget about the SP fluctuations(you have no control over it), and focus on TLT rock solid data, and the fact that TLT is the only Pharmaceutical Company in the world that has a very good '' one and done'' treatment for BCG resistant patients in a FDA phase11 trial, and to top it off, TLT has the most impressive data in the business.

Financing.
Financing is TLT management job, and up until now management has always found ways to finance TLT, and that will not change.

Extra note:
-ImmunityBio has Anktiva, a 37 months long treatments that doesn't even cure the Bladder Cancer.
-ImmunityBio has a $7.40can SP, and analys't have a $40.can SP projection for ImmunityBio.
-ImmunityBio has a huge 700 million shares out, and there is no talk of a 1 for 3 reverse.... :) :) :) :).....:):):)...:):):)...........
-TLT has 240 million shares out(+300 million fully diluted).

All in all not a bad two weeks.

Hang tight, the best has yet to come.

I love my TLT shares.


.


<< Previous
Bullboard Posts
Next >>